Zobrazeno 61 - 70
of 227
pro vyhledávání: '"Shigeki Ohtake"'
Autor:
Minoru Yoshida, Naoko Hatsumi, Katsuyuki Kito, Hisashi Sakamaki, Shuichi Miyawaki, Yoshinobu Kanda, Kazuyuki Shigeno, Tomoki Naoe, R Ohno, Kazunori Ohnishi, Nobu Akiyama, Hiroshi Handa, Masatomo Takahashi, Hiroyuki Fujita, Katsuhiro Miura, Jun-ichi Miyatake, Shigeki Ohtake
Publikováno v:
International Journal of Hematology. 93:66-73
We analyzed the incidence and prognosis of bacteremia/fungemia and pneumonia during remission induction therapy of a newly diagnosed acute myelogenous leukemia (AML) in the Japan Adult Leukemia Study Group treated with individual protocols of AML-87/
Autor:
Atsushi Fujieda, Hisashi Sakamaki, Yasushi Miyazaki, Tadashi Nagai, Hirokazu Okumura, Hitoshi Kiyoi, Shigeki Ohtake, Noriko Usui, Hiroyuki Fujita, Takeshi Hagino, Shuichi Miyawaki, Noriko Doki, Kaito Harada, Ryuzo Ohno, Kazuteru Ohashi, Takahisa Yamane, Koichi Miyamura, Kazunori Ohnishi, Chiaki Nakaseko, Tomoki Naoe
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 16:S19-S20
Autor:
Shin Matsuda, Masatomo Takahashi, Yuji Kishimoto, Yasushi Miyazaki, Ryuzo Ohno, Kinuko Mitani, Nobuhiko Emi, Norio Asou, Shigeki Ohtake, Fumiharu Yagasaki, Sumihisa Honda, Shuichi Miyawaki, Hisashi Sakamaki, Yoshiaki Ogawa
Publikováno v:
International Journal of Hematology. 91:284-292
We prospectively compared allogeneic hematopoietic stem cell transplantation (allo-HSCT) with chemotherapy as a post-remission therapy in a multicenter trial (JALSG AML97) of adult patients with intermediate or poor risk acute myeloid leukemia (AML).
Autor:
Hisashi Sakamaki, Masao Tomonaga, Tomoko Hata, Shuichi Miyawaki, Kazutaka Kuriyama, Yasushi Miyazaki, Shigeki Ohtake, Masafumi Taniwaki, Moe Wakui, Tomoki Naoe, Ryuzo Ohno
Publikováno v:
International Journal of Hematology
We reviewed and categorized 638 of 809 patients who were registered in the Japan Adult Leukemia Study Group acute myeloid leukemia (AML)-97 protocol using morphological means. Patients with the M3 subtype were excluded from the study group. According
Autor:
Shigeru Shimadoi, Yukio Kondo, Akiyoshi Takami, Shinji Nakao, Hirohito Yamazaki, Shigeki Ohtake, Masahide Yasui, Yuko Waseda, Hiroshi Date, Yasuo Ontachi, Hirokazu Okumura, Jun Ozaki
Publikováno v:
International journal of hematology. 86(4):369-373
金沢大学付属病院血液内科
We report a successful case of living-donor lobar lung transplantation (LDLLT) for therapy-resistant broncho-bronchiolitis obliterans (BBO) after allogeneic hematopoietic stem cell transplantation (HSCT). Bro
We report a successful case of living-donor lobar lung transplantation (LDLLT) for therapy-resistant broncho-bronchiolitis obliterans (BBO) after allogeneic hematopoietic stem cell transplantation (HSCT). Bro
Autor:
Yukihiko Kimura, Tomoki Naoe, Akihiro Takeshita, Masako Iwanaga, Norio Asou, Katsuji Shinagawa, Tohru Kobayashi, Masaya Okada, Shigeki Ohtake, Hitoshi Kiyoi, Masatomo Takahashi, Fumiharu Yagasaki, Motohiro Tsuzuki, Mitsuhiro Matsuda, Miki Nishimura, Ryuzo Ohno, Yasukazu Kawai, Kentaro Horikawa, Yuji Kishimoto
Publikováno v:
Blood. 110:59-66
To examine the efficacy of intensified maintenance chemotherapy, we conducted a prospective multicenter trial in adult patients with newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Of the 302 regist
Publikováno v:
Journal of atherosclerosis and thrombosis. 22(7)
Aim 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) are cholesterol-lowering drugs with a variety of pleiotropic effects including antithrombotic properties. Tissue factor pathway inhibitor (TFPI), which is produced predominantly
Autor:
Hirohito Yamazaki, Takeharu Kotani, Akiyoshi Takami, Hirokazu Okumura, Mikio Ueda, Chiharu Sugimori, Naomi Sugimori, Masaki Yamaguchi, Shinji Nakao, Tatsuya Chuhjo, Jun Ozaki, Yukio Kondo, Shigeki Ohtake
Publikováno v:
European Journal of Haematology. 78:157-160
Human leukocyte antigen (HLA)-mismatched stem cell transplantation from non-inherited maternal antigen (NIMA)-complementary donors is known to produce stable engraftment without inducing severe graft-versus-host disease (GVHD). We treated two patient
Autor:
Hidesaku Asakura, Shinji Nakao, Tomonori Sekino, Yasuo Midate, Tomoe Hayashi, Tomotaka Yoshida, Eriko Morishita, Kazumi Yamazaki, Shigeki Ohtake, Masahide Yamazaki, Kyoko Hirano
Publikováno v:
Japanese Journal of Thrombosis and Hemostasis. 17:454-461
Autor:
Yoshiaki Ogawa, Norio Asou, Sumihisa Honda, Fumiharu Yagasaki, Yuji Kishimoto, Masatomo Takahashi, Shin Matsuda, Nobuhiko Emi, Hisashi Sakamaki, Ryuzo Ohno, Yasushi Miyazaki, Shuichi Miyawaki, Kinuko Mitani, Shigeki Ohtake, Takafumi Matsushima
Publikováno v:
Cancer. 104:2726-2734
BACKGROUND A major concern in the treatment of patients with acute myeloid leukemia (AML) is how to prevent disease recurrences. Although intensive consolidation therapy has proven useful, the effectiveness of maintenance therapy remains controversia